Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:49 AM
Ignite Modification Date:
2025-12-26 @ 11:49 AM
NCT ID:
NCT00001016
Eligibility Criteria:
Inclusion Criteria
Concurrent Medication:
Allowed:
* Blood pressure medication.
Concurrent Treatment:
Allowed:
* Blood products.
* Ventilatory support.
Patients must have the following:
* Diagnosis of Pneumocystis carinii pneumonia (PCP).
* Be HIV positive by ELISA, HIV culture, or p24 antigenemia; or be a member of an identified risk group.
* Intolerant to trimethoprim / sulfamethoxazole (TMP / SMX).
* Intolerant to pentamidine.
Prior Medication:
Allowed:
* Trimethoprim / sulfamethoxazole trials.
* Pentamidine trials.
* Myelosuppressive agents.
* Nephrotoxic agents.
* Zidovudine (AZT).
Exclusion Criteria
Co-existing Condition:
Patients who do not meet the inclusion criteria are excluded.
Concurrent Medication:
Excluded:
* Myelosuppressive agents.
* Nephrotoxic agents.
* Other investigational drugs including high-dose steroids (exceeding physiologic replacement doses).
Patients who do not meet the inclusion criteria are excluded.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Study:
NCT00001016
Study Brief:
Protocol Section:
NCT00001016